暨南大学药学院学术报告

  
报告人： Prof. Moussa Youdim  
Prof. Yifan Han
报告题目: 1) Novel therapeutic approaches constituting multifunctional neuroprotective and neurorestorative drugs for neurodegenerative diseases. Reported by Prof. Moussa Youdim
2) Discovery and development of novel anti-Alzheimer's dimmers from the Chinese medicinal herbs. Reported by Prof. Yifan Han
报告时间：2010年6月1日下午3:30-5:00
报告地点：教学大楼216教室
邀请人：暨南大学药学院院长王玉强教授
主持人：王玉强院长
 
Introduction of Prof. Moussa Youdim and Prof. Yifan Han
 Prof Moussa Youdim received his graduate education and Ph.D. in Biochemistry at McGill University in Montreal, Canada in 1966, which was followed by 6 years at the University of London and 5 years at the University of Oxford before he settled at his present place in 1977 where he is Professor of Pharmacology, Professor of Life Sciences, and Director of Eve Topf and NPF Centers of Excellence for Neurodegenerative Diseases Research, Technion-Rappaport Family Faculty of Medicine in Haifa, Israel. He led to the development of therapeutically active drugs such as monoamine oxidase and cholinesterase inhibitors, iron inhibitors and to 97 International patents—studies of deprenyl and several multifunctional drugs, the latest among them is Rasagline, which is used as an anti Parkinson and Alzheimer—Lewy Body disease drug now in major clinical trials. In addition, he has patents and findings for treatments of cardiovascular disorders, diagnostic tests for Parkinson’s, and treatment of renal failure.
 
Prof Yifan Han was trained as a pharmacologist with a background in traditional Chinese medicines at the School of Pharmacy, Shanghai First Medical College, and the Peking Union Medical College, respectively.  He earned his Ph.D. from the Medical College of Ohio, USA.  After completing Post-doctoral training at the National Institutes of Health in USA, he joined the Hong Kong University of Science and Technology in 1994, and moved to the Hong Kong Polytechnic University in 2007.  His research focus is on the discovery and development of novel drugs derived from the Chinese medicines for Alzheimer’s and other related neurodegenerative diseases.  His work has resulted in numerous publications and several international patents.
 
竭诚欢迎广大师生莅临！                               
2010年5月31日
 
 

作者：吉念宁